Ubs Group Ag G1 Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.2 - $4.98 $192,123 - $434,898	87,329 Added 28353.57%	87,637 $199,000
Q1 2024 May 13, 2024	SELL	$2.1 - $4.83 $6,031 - $13,871	-2,872 Reduced 90.31%	308 $1,000
Q4 2023 Feb 09, 2024	BUY	$1.12 - $3.73 $3,323 - $11,066	2,967 Added 1392.96%	3,180 $9,000
Q3 2023 Nov 09, 2023	SELL	$1.22 - $2.67 $3,051 - $6,677	-2,501 Reduced 92.15%	213 $0
Q2 2023 Aug 11, 2023	SELL	$2.46 - $3.14 $8,824 - $11,263	-3,587 Reduced 56.93%	2,714 $6,000
Q1 2023 May 12, 2023	SELL	$2.57 - $8.16 $4,322 - $13,725	-1,682 Reduced 21.07%	6,301 $16,000
Q4 2022 Feb 08, 2023	SELL	$5.19 - $13.5 $249,120 - $648,000	-48,000 Reduced 85.74%	7,983 $43,000
Q3 2022 Nov 10, 2022	BUY	$5.17 - $16.99 $288,330 - $947,532	55,770 Added 26183.1%	55,983 $700,000
Q2 2022 Aug 10, 2022	SELL	$4.04 - $8.51 $899,732 - $1.9 Million	-222,706 Reduced 99.9%	213 $1,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $264,480 - $383,496	-34,800 Reduced 13.5%	222,919 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $1.39 Million - $2.22 Million	137,157 Added 113.76%	257,719 $2.63 Million
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $1.39 Million - $2.37 Million	105,274 Added 688.61%	120,562 $1.62 Million
Q2 2021 Aug 13, 2021	SELL	$19.57 - $26.32 $1 Million - $1.35 Million	-51,183 Reduced 77.0%	15,288 $335,000
Q1 2021 May 12, 2021	BUY	$17.58 - $32.59 $1.16 Million - $2.16 Million	66,258 Added 31107.04%	66,471 $1.6 Million
Q4 2020 Feb 11, 2021	SELL	$10.99 - $20.4 $54,950 - $102,000	-5,000 Reduced 95.91%	213 $4,000
Q3 2020 Nov 12, 2020	BUY	$11.55 - $23.75 $42,134 - $86,640	3,648 Added 233.1%	5,213 $60,000
Q2 2020 Jul 31, 2020	SELL	$9.57 - $24.37 $87,670 - $223,253	-9,161 Reduced 85.41%	1,565 $38,000
Q1 2020 May 01, 2020	SELL	$9.07 - $26.32 $151,323 - $439,122	-16,684 Reduced 60.87%	10,726 $118,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $806,420 - $1.22 Million	-39,261 Reduced 58.89%	27,410 $725,000
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $1.13 Million - $2.01 Million	49,598 Added 290.51%	66,671 $1.52 Million
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $262,250 - $508,796	16,360 Added 2294.53%	17,073 $524,000
Q1 2019 May 14, 2019	SELL	$14.4 - $21.45 $1.35 Million - $2 Million	-93,428 Reduced 99.24%	713 $12,000
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $1.43 Million - $4.43 Million	86,380 Added 1113.0%	94,141 $1.8 Million
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $240,259 - $378,456	5,568 Added 253.9%	7,761 $406,000
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $38,320 - $55,928	1,093 Added 99.36%	2,193 $95,000
Q1 2018 May 15, 2018	SELL	$19.05 - $41.76 $4,838 - $10,607	-254 Reduced 18.76%	1,100 $40,000
Q4 2017 Feb 14, 2018	BUY	$19.01 - $26.2 $18,135 - $24,994	954 Added 238.5%	1,354 $27,000
Q3 2017 Nov 14, 2017	SELL	$12.53 - $27.12 $6,202 - $13,424	-495 Reduced 55.31%	400 $10,000
Q2 2017 Aug 14, 2017	BUY	N/A	895	895 $15,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account